Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 58042-39-0 Chemical Structure| 58042-39-0

Structure of 58042-39-0

Chemical Structure| 58042-39-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 58042-39-0 ]

CAS No. :58042-39-0
Formula : C9H13NO3S
M.W : 215.27
SMILES Code : O=S(C1=C(C)C=C(C)C=C1C)(NO)=O
MDL No. :MFCD16309113
InChI Key :RRPKGUUYTHFUPN-UHFFFAOYSA-N
Pubchem ID :11009332

Safety of [ 58042-39-0 ]

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H302+H312+H332-H315-H319-H228
Precautionary Statements:P261-P210-P264-P280-P370+P378-P302+P352+P312
Class:4.1
UN#:1325
Packing Group:

Computational Chemistry of [ 58042-39-0 ] Show Less

Physicochemical Properties

Num. heavy atoms 14
Num. arom. heavy atoms 6
Fraction Csp3 0.33
Num. rotatable bonds 2
Num. H-bond acceptors 4.0
Num. H-bond donors 2.0
Molar Refractivity 53.16
TPSA ?

Topological Polar Surface Area: Calculated from
Ertl P. et al. 2000 J. Med. Chem.

74.78 Ų

Lipophilicity

Log Po/w (iLOGP)?

iLOGP: in-house physics-based method implemented from
Daina A et al. 2014 J. Chem. Inf. Model.

1.57
Log Po/w (XLOGP3)?

XLOGP3: Atomistic and knowledge-based method calculated by
XLOGP program, version 3.2.2, courtesy of CCBG, Shanghai Institute of Organic Chemistry

1.49
Log Po/w (WLOGP)?

WLOGP: Atomistic method implemented from
Wildman SA and Crippen GM. 1999 J. Chem. Inf. Model.

2.36
Log Po/w (MLOGP)?

MLOGP: Topological method implemented from
Moriguchi I. et al. 1992 Chem. Pharm. Bull.
Moriguchi I. et al. 1994 Chem. Pharm. Bull.
Lipinski PA. et al. 2001 Adv. Drug. Deliv. Rev.

1.25
Log Po/w (SILICOS-IT)?

SILICOS-IT: Hybrid fragmental/topological method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

0.81
Consensus Log Po/w?

Consensus Log Po/w: Average of all five predictions

1.5

Water Solubility

Log S (ESOL):?

ESOL: Topological method implemented from
Delaney JS. 2004 J. Chem. Inf. Model.

-2.3
Solubility 1.08 mg/ml ; 0.00503 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (Ali)?

Ali: Topological method implemented from
Ali J. et al. 2012 J. Chem. Inf. Model.

-2.67
Solubility 0.463 mg/ml ; 0.00215 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble
Log S (SILICOS-IT)?

SILICOS-IT: Fragmental method calculated by
FILTER-IT program, version 1.0.2, courtesy of SILICOS-IT, http://www.silicos-it.com

-2.97
Solubility 0.232 mg/ml ; 0.00108 mol/l
Class?

Solubility class: Log S scale
Insoluble < -10 < Poorly < -6 < Moderately < -4 < Soluble < -2 Very < 0 < Highly

Soluble

Pharmacokinetics

GI absorption?

Gatrointestinal absorption: according to the white of the BOILED-Egg

High
BBB permeant?

BBB permeation: according to the yolk of the BOILED-Egg

Yes
P-gp substrate?

P-glycoprotein substrate: SVM model built on 1033 molecules (training set)
and tested on 415 molecules (test set)
10-fold CV: ACC=0.72 / AUC=0.77
External: ACC=0.88 / AUC=0.94

No
CYP1A2 inhibitor?

Cytochrome P450 1A2 inhibitor: SVM model built on 9145 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.83 / AUC=0.90
External: ACC=0.84 / AUC=0.91

No
CYP2C19 inhibitor?

Cytochrome P450 2C19 inhibitor: SVM model built on 9272 molecules (training set)
and tested on 3000 molecules (test set)
10-fold CV: ACC=0.80 / AUC=0.86
External: ACC=0.80 / AUC=0.87

No
CYP2C9 inhibitor?

Cytochrome P450 2C9 inhibitor: SVM model built on 5940 molecules (training set)
and tested on 2075 molecules (test set)
10-fold CV: ACC=0.78 / AUC=0.85
External: ACC=0.71 / AUC=0.81

No
CYP2D6 inhibitor?

Cytochrome P450 2D6 inhibitor: SVM model built on 3664 molecules (training set)
and tested on 1068 molecules (test set)
10-fold CV: ACC=0.79 / AUC=0.85
External: ACC=0.81 / AUC=0.87

No
CYP3A4 inhibitor?

Cytochrome P450 3A4 inhibitor: SVM model built on 7518 molecules (training set)
and tested on 2579 molecules (test set)
10-fold CV: ACC=0.77 / AUC=0.85
External: ACC=0.78 / AUC=0.86

No
Log Kp (skin permeation)?

Skin permeation: QSPR model implemented from
Potts RO and Guy RH. 1992 Pharm. Res.

-6.56 cm/s

Druglikeness

Lipinski?

Lipinski (Pfizer) filter: implemented from
Lipinski CA. et al. 2001 Adv. Drug Deliv. Rev.
MW ≤ 500
MLOGP ≤ 4.15
N or O ≤ 10
NH or OH ≤ 5

0.0
Ghose?

Ghose filter: implemented from
Ghose AK. et al. 1999 J. Comb. Chem.
160 ≤ MW ≤ 480
-0.4 ≤ WLOGP ≤ 5.6
40 ≤ MR ≤ 130
20 ≤ atoms ≤ 70

None
Veber?

Veber (GSK) filter: implemented from
Veber DF. et al. 2002 J. Med. Chem.
Rotatable bonds ≤ 10
TPSA ≤ 140

0.0
Egan?

Egan (Pharmacia) filter: implemented from
Egan WJ. et al. 2000 J. Med. Chem.
WLOGP ≤ 5.88
TPSA ≤ 131.6

0.0
Muegge?

Muegge (Bayer) filter: implemented from
Muegge I. et al. 2001 J. Med. Chem.
200 ≤ MW ≤ 600
-2 ≤ XLOGP ≤ 5
TPSA ≤ 150
Num. rings ≤ 7
Num. carbon > 4
Num. heteroatoms > 1
Num. rotatable bonds ≤ 15
H-bond acc. ≤ 10
H-bond don. ≤ 5

0.0
Bioavailability Score?

Abbott Bioavailability Score: Probability of F > 10% in rat
implemented from
Martin YC. 2005 J. Med. Chem.

0.55

Medicinal Chemistry

PAINS?

Pan Assay Interference Structures: implemented from
Baell JB. & Holloway GA. 2010 J. Med. Chem.

0.0 alert
Brenk?

Structural Alert: implemented from
Brenk R. et al. 2008 ChemMedChem

1.0 alert: heavy_metal
Leadlikeness?

Leadlikeness: implemented from
Teague SJ. 1999 Angew. Chem. Int. Ed.
250 ≤ MW ≤ 350
XLOGP ≤ 3.5
Num. rotatable bonds ≤ 7

No; 1 violation:MW<1.0
Synthetic accessibility?

Synthetic accessibility score: from 1 (very easy) to 10 (very difficult)
based on 1024 fragmental contributions (FP2) modulated by size and complexity penaties,
trained on 12'782'590 molecules and tested on 40 external molecules (r2 = 0.94)

2.41

Application In Synthesis of [ 58042-39-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 58042-39-0 ]

[ 58042-39-0 ] Synthesis Path-Downstream   1~17

  • 1
  • [ 18438-38-5 ]
  • [ 58042-39-0 ]
  • methyl-2-pyridylaminosulfonium mesitylenesulfonate [ No CAS ]
  • 2
  • [ 19006-76-9 ]
  • [ 58042-39-0 ]
  • C9H11O3S(1-)*C7H11N2S(1+) [ No CAS ]
  • 3
  • [ 244-69-9 ]
  • [ 58042-39-0 ]
  • 2-amino-γ-carbolinium mesitylenesulfonate [ No CAS ]
  • 4
  • [ 51290-79-0 ]
  • [ 58042-39-0 ]
  • C9H11O3S(1-)*C8H13N2S(1+) [ No CAS ]
  • 5
  • [ 51290-79-0 ]
  • [ 58042-39-0 ]
  • C12H13N2S(1+)*C9H11O3S(1-) [ No CAS ]
  • 6
  • [ 52197-08-7 ]
  • [ 58042-39-0 ]
  • C9H11O3S(1-)*C6H9N2OS(1+) [ No CAS ]
  • 7
  • [ 58086-68-3 ]
  • [ 58042-39-0 ]
  • C13H15N2S(1+)*C9H11O3S(1-) [ No CAS ]
  • 8
  • [ 77037-68-4 ]
  • [ 58042-39-0 ]
  • C11H14N4S2(2+)*2C9H11O3S(1-) [ No CAS ]
  • 9
  • [ 58042-39-0 ]
  • [ 76456-09-2 ]
  • C15H25N2S(1+)*C9H11O3S(1-) [ No CAS ]
  • 10
  • [ 475174-64-2 ]
  • [ 58042-39-0 ]
  • [ 475174-67-5 ]
YieldReaction ConditionsOperation in experiment
In dichloromethane; for 0.5h; [0194] To a solution of 2-(1-butynyl)pyridine (12.8 g) dissolved in dichloromethane (60 mL) was added a solution of <strong>[58042-39-0]O-<strong>[58042-39-0]mesitylenesulfonylhydroxylamine</strong></strong> (Reference; Synthesis, 1997, 1) (20 g) in dichloromethane (132 mL) while cooling with ice, and the reaction mixture was stirred for 30 minutes. Diethyl ether (2 L) was added to the reaction mixture to precipitate crystals, which were filtered off and then dried under reduced pressure to afford a crude product of N-amino-2-(1-butynyl)pyridinium mesitylenesulfonate (12.6 g) as colorless crystals. [0195] A portion (6.1 g) of the obtained crude product of N-amino-2-(1-butynyl)pyridinium mesitylenesulfonate was dissolved in tetrahydrofuran (600 mL), and then potassium tert-butoxide (3.55 g) was added thereto at room temperature and the reaction mixture was vigorously stirred for 30 minutes. After adding ice water to the obtained reaction mixture, extraction was performed with ethyl acetate. After re-extraction of the aqueous layer with ethyl acetate and the insoluble residue was filtered with celite, the organic extracts were combined and washed with brine. The obtained organic extract was dried over anhydrous magnesium sulfate and filtered, the solvent was evaporated under reduced pressure, the residue was purified by silica gel column chromatography and the title compound (0.63 g) was obtained as a light yellow oil from the n-hexane:ethyl acetate (10:1) fraction. [0196] 1H NMR (400 MHz, CDCl3) delta 1.36 (t, J=7.6 Hz, 3H), 2.86 (q, J=7.6 Hz, 2H), 6,30 (s, 1H), 6.65 (ddd, J=1.6, 6.8, 6.8 Hz, 1H), 7.04 (ddd, J=1.2, 6.8, 8.8 Hz, 1H), 7.41 (ddd, J=1.2, 1.2, 8.8 Hz, 1H), 8.37 (ddd, J=1.2, 1.2, 6.8 Hz, 1H).
  • 11
  • [ 58042-39-0 ]
  • [ 113985-43-6 ]
  • [ 685886-58-2 ]
YieldReaction ConditionsOperation in experiment
In dichloromethane; for 0.5h; [0239] To a solution of 2-(3-methoxy-1-propynyl)pyridine (13.2 g) dissolved in dichloromethane (50 mL) was added a solution of <strong>[58042-39-0]O-<strong>[58042-39-0]mesitylenesulfonylhydroxylamine</strong></strong> (Reference; Synthesis, 1997, 1) (21 g) in dichloromethane (80 mL) dropwise while cooling with ice, and the reaction mixture was stirred for 30 minutes. Diethyl ether (1 L) was added to the obtained reaction mixture to precipitate crystals, which were collected by filtration and dried under reduced pressure to afford a crude product of 1-amino-2-(3-methoxy-1-propynyl)pyridinium 2,4,6-trimethyl-1-benzenesulfonate as ecru crystals (27.1 g). [0240] To a solution of the obtained crude product of 1-amino-2-(3-methoxy-1-propynyl)pyridinium 2,4,6-trimethyl-1-benzenesulfonate (27.1 g) dissolved in methanol (100 mL) was added sodium methoxide (28% methanol solution; 14.3 mL) dropwise while cooling with ice, and the reaction mixture was stirred for 20 minutes at room temperature. After adding ice water to the obtained reaction mixture, the methanol was evaporated under reduced pressure, water was added to the residue and extraction was performed 3 times with ethyl acetate. The organic extracts were combined, washed with brine, dried over anhydrous magnesium sulfate and filtered, and the solvent was evaporated under reduced pressure. The residue was purified by silica gel column chromatography and the title compound (3.54 g) was obtained as a light orange oil from the n-hexane:ethyl acetate (5:1) fraction. [0241] 1H NMR (400 MHz, CDCl3) delta 3.47 (s, 3H), 4.68 (s, 2H), 6.50 (s, 1H), 6.70-6.75 (m, 1H), 7.06-7.11 (m, 1H), 7.47-7.50 (m, 1H), 8.40-8.43 (m, 1H).
  • 12
  • [ 141429-31-4 ]
  • [ 58042-39-0 ]
  • Ethyl 1-Amino-6,7-difluoro-8-acetoxymethyl-1,4-dihydro-4-oxoquinoline-3-carboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
57% With potassium carbonate; In dichloromethane; water; N,N-dimethyl-formamide; EXAMPLE 14 Ethyl 1-Amino-6,7-difluoro-8-acetoxymethyl-1,4-dihydro-4-oxoquinoline-3-carboxylate (97): 10.7 g (32.9 mmol) of ethyl 6,7-difluoro-4-hydroxy-8-acetoxymethylquinoline-3-carboxylate and 14.2 g (65.8 mmol) of anhydrous potassium carbonate were added to 130 ml of N,N-dimethylformamide, and the solution was stirred at room temperature for 4 hours. 14 g (NET 8.97 g, 49 mmol) of mesitylenesulfonylhydroxyamine was dissolved in 100 ml of methylene chloride, and after drying over sodium sulfate, while cooling on ice, this solution was dropped to the previous solution through 20 minutes. Then, the obtained solution was left overnight as it was. To this solution, 100 ml of water was added, and the solution was stirred at room temperature for 1 hour. The solution was extracted with methylene chloride, and the organic layer was washed. After drying over sodium sulfate, the solvent was removed under reduced pressure and ether was added to the crystal residue. The crystals were filtered off and washed with ether to obtain 6.4 g of the subject compound (97) in a 57% yield. The results of the analysis of this compound were as follows: Colorless needles: Melting point: 217-221 C. (decomp.) 1 H-NMR (DMSO-d6): 1.28 (t, J=7.3 Hz, 3H), 2.05 (s, 3H), 4.25 (q, J=7.3 Hz, 2H), 5.74 (s, 2H), 6.59 (brs, 2H), 8.15 (dd, J=9.2 Hz, 10.3 Hz, 1H), 8.59 (s, 1H)
  • 13
  • [ 58042-39-0 ]
  • [ 33282-64-3 ]
  • [ 127984-93-4 ]
YieldReaction ConditionsOperation in experiment
55% In dichloromethane; water; SYNTHESIS EXAMPLE 2 1-Amino-5-bromouracil After the silylation of 5-bromouracil conducted in the same manner as in Synthesis Example 1, 8.8 g (26 mmole) of 5-bromo-2,4-ditrimethylsilyloxypyrimidine distilled and purified was dissolved in 50 ml of dichloromethane. To the solution was added 6.7 g (31 mmole) of <strong>[58042-39-0]MSH</strong> under ice-cooling, and the mixture was reacted with stirring at room temperature for 4 hours. After reaction, the reaction solution was concentrated under reduced pressure. To the residue were added distilled water (200 ml) and subsequently 2N-sodium hydroxide to adjust the pH to 6.0, and the solution was concentrated under reduced pressure. The crude product thus obtained was collected by filtration and recrystallized from 50% ethanol to give 3 g (yield, 55%) of crystalline 1-amino-5-bromouracil. M.P.: 214-215 C. Elementary analysis for C4 H4 N3 O2 Br;
  • 14
  • [ 58042-39-0 ]
  • [ 17242-85-2 ]
  • [ 91286-55-4 ]
YieldReaction ConditionsOperation in experiment
In dichloromethane; water; SYNTHESIS EXAMPLE 1 1-Amino-5-fluorouracil 5-Fluorouracil was silylated as usual with hexamethyldisilazane, and then 8.8 g (32 mmole) of 2,4-ditrimethylsilyloxy-5-fluoropyrimidine thus obtained, distilled and purified was dissolved in dichloromethane (48 ml). To the solution was added 7.5 g (35 mmole) of <strong>[58042-39-0]mesitylenesulfonylhydroxylamine</strong> (<strong>[58042-39-0]MSH</strong>) under ice-cooling, and the mixture was reacted with stirring at room temperature for 4 hours. After reaction, the reaction solution was concentrated under reduced pressure. Distilled water (200 ml) was added to the residue, and oily impurities were extracted with chloroform (50 ml) from the mixture. The aqueous phase was neutralized with a weakly basic resin and then concentrated to dryness under reduced pressure. The crude crystal thus obtained was purified by sublimation under the conditions of 150 C. and 5 mmHg to give 2.9 g (yield, 62%) of 1-amino-5-fluorouracil. The product was further recrystallized from 50% ethanol to give colorless needle crystals. M.P. 196-199 C. (lit. 205-207 C.) Elementary analysis for C4 H4 N3 O2 F:
  • 15
  • [ 58762-19-9 ]
  • [ 58042-39-0 ]
  • [ 58762-20-2 ]
YieldReaction ConditionsOperation in experiment
With sodium hydroxide; In dichloromethane; IR Spectrum: =NH at 3290cm-1; -COOCH3 at 1730cm-1; and xanthone carbonyl at 1665cm-1. In another method, 108 mg (0.5 mmole) of O-mesitylene sulfonyl hydroxylamine were added to a solution of 100 mg (0.25 mmole) of methyl 7-(methylsulfinyl)-5-(n-pentyloxy)-xanthone-2-carboxylate in 10 ml of dichloromethane and the solution was stirred at room temperature for 2 days after which only a trace of sulfoxide remained. The mixture was poured into 25 ml of 10% sodium hydroxide solution and after stirring for 10 minutes, the organic layer was removed. The aqueous layer was extracted twice with dichloromethane and the combined extracts were dried over magnesium sulfate and evaporated to dryness to obtain an oil residue which was triturated with ethyl acetate to obtain 51 mg of methyl 7-(S-methylsulfonimidoyl)-5-(n-pentyloxy)-xanthone-2-carboxylate as white crystals.
  • 16
  • [ 773-64-8 ]
  • [ 58042-39-0 ]
YieldReaction ConditionsOperation in experiment
74% With dmap; hydroxylamine hydrochloride; In pyridine; at 20.0℃; for 0.08333330000000001h;Cooling with ice; General procedure: To a mixture of hydroxylamine hydrochloride (2 equiv.) and DMAP (2 equiv.) in pyridine (20 mL) was added a portion of arylsulfonyl chloride (1 equiv.) on an ice-bath. Then, the mixture was stirred for 5 min at room temperature. The resulting suspension was poured into AcOEt (100 mL) and 1 N HCl aq. (100 mL). The AcOEt layer was separated, washed with brine (100 mL), dried over Na2SO4, filtered and concentrated. The crude product was purified by flash column chromatography under one of the gradient conditions indicated below, and recrystallized from Et2O/n-hexane to give N-hydroxyarylsulfonamide derivatives.
  • 17
  • [ 120-72-9 ]
  • [ 58042-39-0 ]
  • [ 1448709-51-0 ]
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 58042-39-0 ]

Aryls

Chemical Structure| 88-19-7

A148820 [88-19-7]

2-Methylbenzenesulfonamide

Similarity: 0.87

Chemical Structure| 16182-15-3

A943439 [16182-15-3]

2,4,6-Trimethylbenzenesulfonohydrazide

Similarity: 0.82

Chemical Structure| 2618-96-4

A177779 [2618-96-4]

Dibenzenesulfonimide

Similarity: 0.81

Chemical Structure| 70-55-3

A180022 [70-55-3]

4-Methylbenzenesulfonamide

Similarity: 0.79

Chemical Structure| 6973-09-7

A135739 [6973-09-7]

5-Amino-2-methylbenzenesulfonamide

Similarity: 0.75

Amines

Chemical Structure| 88-19-7

A148820 [88-19-7]

2-Methylbenzenesulfonamide

Similarity: 0.87

Chemical Structure| 16182-15-3

A943439 [16182-15-3]

2,4,6-Trimethylbenzenesulfonohydrazide

Similarity: 0.82

Chemical Structure| 2618-96-4

A177779 [2618-96-4]

Dibenzenesulfonimide

Similarity: 0.81

Chemical Structure| 70-55-3

A180022 [70-55-3]

4-Methylbenzenesulfonamide

Similarity: 0.79

Chemical Structure| 6973-09-7

A135739 [6973-09-7]

5-Amino-2-methylbenzenesulfonamide

Similarity: 0.75

Hydroxylamines

Chemical Structure| 414864-00-9

A110435 [414864-00-9]

N-Hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide

Similarity: 0.51

Sulfamides

Chemical Structure| 88-19-7

A148820 [88-19-7]

2-Methylbenzenesulfonamide

Similarity: 0.87

Chemical Structure| 16182-15-3

A943439 [16182-15-3]

2,4,6-Trimethylbenzenesulfonohydrazide

Similarity: 0.82

Chemical Structure| 2618-96-4

A177779 [2618-96-4]

Dibenzenesulfonimide

Similarity: 0.81

Chemical Structure| 70-55-3

A180022 [70-55-3]

4-Methylbenzenesulfonamide

Similarity: 0.79

Chemical Structure| 6973-09-7

A135739 [6973-09-7]

5-Amino-2-methylbenzenesulfonamide

Similarity: 0.75